Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.
Cite
CITATION STYLE
APA
Hill, F., Miller, N., Walsh, R. A., Mockler, D., Mcdowell, R., & Walshe, M. (2016). Botulinum toxin for drooling in Parkinson’s disease. Cochrane Database of Systematic Reviews, 2016(10). https://doi.org/10.1002/14651858.CD012408
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free